- Conditions
- Partial Seizures
- Interventions
- Divalproex Sodium (Depakote Sprinkle Capsules)
- Drug
- Lead sponsor
- Abbott
- Industry
- Eligibility
- 3 Years to 10 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2005
- U.S. locations
- 10
- States / cities
- Northport, Alabama • Phoenix, Arizona • Tampa, Florida + 7 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 49–72
of 108
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Brain Injuries, Acute, Brain Injuries, Traumatic, Brain Ischemia, Brain Hypoxia, Hypoxia-Ischemia, Brain, Heart Arrest, Stroke, Intracranial Hemorrhages, Coma, Persistent Vegetative State
- Interventions
- Phenobarbital Sodium Injection, Levetiracetam, Lacosamide Injectable Product, Valproate Sodium, Fosphenytoin
- Drug
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 18 Months to 70 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina
- Conditions
- PTSD
- Interventions
- Divalproex, placebo
- Drug · Other
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 19 Years to 65 Years
- Enrollment
- 101 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2005
- U.S. locations
- 1
- States / cities
- Tuscaloosa, Alabama
- Conditions
- Epilepsy
- Interventions
- Compliance
- Behavioral
- Lead sponsor
- Orlando Health, Inc.
- Other
- Eligibility
- 16 Years to 99 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2007
- U.S. locations
- 1
- States / cities
- Orlando, Florida
- Conditions
- Moderate Traumatic Brain Injury (TBI), Severe Traumatic Brain Injury
- Interventions
- Valproic Acid (VPA), Standard of care treatment + normal saline
- Drug · Other
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 432 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2027 – 2031
- U.S. locations
- 8
- States / cities
- Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 5 more
- Conditions
- Attention Deficit Disorder With Hyperactivity
- Interventions
- Valproate, Risperidone, Placebo, Stimulant medication, Behavioral family counseling
- Drug · Behavioral
- Lead sponsor
- Joseph Blader
- NIH
- Eligibility
- 6 Years to 12 Years
- Enrollment
- 270 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2013
- U.S. locations
- 3
- States / cities
- Glen Oaks, New York • Stony Brook, New York • San Antonio, Texas
- Conditions
- Bipolar I Disorder
- Interventions
- Divalproex Sodium (Depakote ER)
- Drug
- Lead sponsor
- Abbott
- Industry
- Eligibility
- 10 Years to 17 Years
- Enrollment
- 227 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2005
- U.S. locations
- 29
- States / cities
- San Diego, California • San Marcos, California • Altamonte Springs, Florida + 25 more
- Conditions
- Alzheimer's Disease, Dementia, Behavioral Symptoms
- Interventions
- Divalproex ER, Quetiapine
- Drug
- Lead sponsor
- University of Cincinnati
- Other
- Eligibility
- 55 Years to 85 Years
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2007
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- Mood Disorders
- Interventions
- Divalproex Sodium (Depakote)
- Drug
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- NIH
- Eligibility
- 7 Years to 11 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2005
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Acute Kidney Injury, Ischemia Reperfusion Injury
- Interventions
- Valproic Acid Solution, Isotonic saline solution
- Drug
- Lead sponsor
- Westat
- Other
- Eligibility
- 18 Years to 80 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 2
- States / cities
- Baltimore, Maryland • Seattle, Washington
- Conditions
- Schizophrenia, Bipolar Disorder, Psychotic Disorders
- Interventions
- divalproex sodium ER/paliperidone ER
- Drug
- Lead sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009
- U.S. locations
- 3
- States / cities
- Kissimmee, Florida • Austin, Texas • Portsmount, Virginia
- Conditions
- Mixed Mania Bipolar Disorder
- Interventions
- Lamotrigine, Sodium Valproate
- Drug
- Lead sponsor
- Beth Israel Medical Center
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2007
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Hematuria, Bladder Cancer
- Interventions
- Valproic Acid
- Drug
- Lead sponsor
- State University of New York - Upstate Medical University
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- Syracuse, New York
- Conditions
- Bipolar Disorder, Light Sensitivity
- Interventions
- Light intensity, ~30 lux, Baseline light intensity, <1 lux
- Other
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 2 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Sensorineural Hearing Loss
- Interventions
- FX-322, Placebo
- Drug
- Lead sponsor
- Frequency Therapeutics
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 23 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Autism, Developmental Delay, Birth Defects
- Interventions
- Not listed
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 36 Months to 83 Months
- Enrollment
- 298 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2010
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Bipolar Disorder
- Interventions
- Divalproex Sodium Extended-Release Tablets
- Drug
- Lead sponsor
- Abbott
- Industry
- Eligibility
- 10 Years to 17 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2003
- U.S. locations
- 16
- States / cities
- Stanford, California • Washington D.C., District of Columbia • Altamonte Springs, Florida + 13 more
- Conditions
- Bipolar Disorder, Mania
- Interventions
- divalproex sodium extended release
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 6 Years to 12 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 1
- States / cities
- Cambridge, Massachusetts
- Conditions
- Bipolar Disorder
- Interventions
- Divalproex sodium extended release
- Drug
- Lead sponsor
- Medical College of Wisconsin
- Other
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2005
- U.S. locations
- 1
- States / cities
- Milwaukee, Wisconsin
- Conditions
- Alcohol Withdrawal Syndrome
- Interventions
- Gabapentin, Benzodiazepines, Divalproex Sodium
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Bipolar Disorder
- Interventions
- Placebo, Ziprasidone
- Drug
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 680 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 66
- States / cities
- Dothan, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 51 more
- Conditions
- Pediatric Epilepsy
- Interventions
- Depakote Delayed-Release/Depakote Sprinkle, Depakote ER
- Drug
- Lead sponsor
- Abbott
- Industry
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003
- U.S. locations
- 1
- States / cities
- Richmond, Virginia
- Conditions
- Bipolar I Disorder, Bipolar II Disorder
- Interventions
- Lithium, Divalproex, Lamotrigine, Quetiapine
- Drug
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 112 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2016
- U.S. locations
- 2
- States / cities
- Cleveland, Ohio • San Antonio, Texas
- Conditions
- Solid Tumor, Adult
- Interventions
- Neratinib, Divalproex Sodium
- Drug
- Lead sponsor
- Virginia Commonwealth University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 83 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2031
- U.S. locations
- 1
- States / cities
- Richmond, Virginia